In 1986 THC was licensed as an anti-emetic drug in cancer patients receiving chemotherapy
In 1986, delta-9-tetrahydrocannabinol (THC), the main effective constituent of cannabis, was licensed as an anti-emetic drug in cancer patients receiving chemotherapy. In addition, in clinical studies, THC has shown significant stimulation of appetite and an increase in body weight in HIV-positive and cancer patients.
What is Endocannabinoid Deficiency?
Have you ever felt tired, forgetful, and head foggy with no apparent reason? Newer research suggests these symptoms may be due to what is known as endocannabinoid deficiency. The Endocannabinoid System It is a part of our nervous system and it is known as the endocannabinoid system. Its job is to keep the body in […]